Price discrimination in the pharmaceutical sector: new decision, but plaintiffs face same challenges October 28, 2015
Outlook for 2015: Antitrust Litigation in the Pharma Industry – More Than Just Actavis Progeny March 20, 2015
Federal Circuit Revives Certain Sham Petitioning Antitrust Counterclaims in Tyco-Mutual ANDA Litigation August 26, 2014
Defining “Payments”: The First Post-Actavis Battleground in Pharmaceutical Reverse Payments May 7, 2014
DOJ and FTC to Shine Spotlight on Analysis of Conditional Pricing Practices Under the Antitrust Laws May 7, 2014
CT AG Leads Charge to Increase Transparency of Hospital-Physician Acquisitions and Facility Fees April 21, 2014
NY Attorney General Forges New Ground in Scrutiny of Pharmaceutical Agreements With First-Filer Exclusivity No-Challenge Settlement February 25, 2014
